Willmott Dixon completes Southampton healthcare R&D facilities

Willmott Dixon has announced the completion of two healthcare R&D facilities in Southampton.

Adanac Health and Innovation Campus (c) Adanac

Adanac Health and Innovation Campus (c) Adanac

Partnering with Prime, Macquarie Group and IHSS, the company has completed an aseptic pharmacy and sterile services department (SSD) at the Adanac Health and Innovation Campus.

The aseptic pharmacy will manufacture sterile medicines for University Hospital Southampton (UHS) and other NHS providers in the region, while the SSD will sterilise medical devices and equipment.

Richard Poulter, managing director at Willmott Dixon in the South, said: ‘We are proud to have played a key role in delivering these state-of-the-art healthcare facilities at Adanac Health and Innovation Campus.

‘This project showcases the power of collaboration in addressing the evolving needs of the NHS and the wider healthcare sector. By combining innovative design, specialist expertise, and a strong sustainability focus, we have created a facility that will make a lasting impact on patient care and medical services across the region.'

Over 40% of patients unaware of how AI is being used in healthcare, poll finds

Over 40% of patients unaware of how AI is being used in healthcare, poll finds

By Liz Wells 02 May 2025

More than four in 10 British people are unaware of how AI is being used in healthcare, a new survey reveals.

Robotic surgery systems approved for NHS use

By Liz Wells 17 April 2025

NICE has approved 11 robotic surgery systems for use, potentially transforming care for thousands of NHS patients undergoing soft tissue and orthopaedic proc...

Government invests in medical research

By Liz Wells 08 April 2025

The Government and the Wellcome Trust will invest up to £600m to transform access to NHS data, by providing a secure single access point to national-scale da...


Popular articles by Lee Peart